JP2014504865A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014504865A5 JP2014504865A5 JP2013547842A JP2013547842A JP2014504865A5 JP 2014504865 A5 JP2014504865 A5 JP 2014504865A5 JP 2013547842 A JP2013547842 A JP 2013547842A JP 2013547842 A JP2013547842 A JP 2013547842A JP 2014504865 A5 JP2014504865 A5 JP 2014504865A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid molecule
- reference nucleic
- binding
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11000117.9 | 2011-01-10 | ||
| EP11000117 | 2011-01-10 | ||
| PCT/EP2011/002068 WO2011131371A1 (en) | 2010-04-21 | 2011-04-21 | Lipid binding nucleic acids |
| EPPCT/EP2011/002068 | 2011-04-21 | ||
| EP11008467 | 2011-10-21 | ||
| EP11008467.0 | 2011-10-21 | ||
| PCT/EP2012/000089 WO2012095303A1 (en) | 2011-01-10 | 2012-01-10 | Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017075557A Division JP2017148055A (ja) | 2011-01-10 | 2017-04-05 | 標的分子との結合親和性を有する核酸分子およびその生成方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014504865A JP2014504865A (ja) | 2014-02-27 |
| JP2014504865A5 true JP2014504865A5 (enExample) | 2015-03-05 |
Family
ID=45464586
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013547842A Pending JP2014504865A (ja) | 2011-01-10 | 2012-01-10 | 標的分子との結合親和性を有する核酸分子およびその生成方法 |
| JP2017075557A Pending JP2017148055A (ja) | 2011-01-10 | 2017-04-05 | 標的分子との結合親和性を有する核酸分子およびその生成方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017075557A Pending JP2017148055A (ja) | 2011-01-10 | 2017-04-05 | 標的分子との結合親和性を有する核酸分子およびその生成方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9976145B2 (enExample) |
| EP (1) | EP2663640B1 (enExample) |
| JP (2) | JP2014504865A (enExample) |
| KR (2) | KR20140026357A (enExample) |
| CN (1) | CN103339258A (enExample) |
| AU (1) | AU2012206750A1 (enExample) |
| CA (1) | CA2824073A1 (enExample) |
| WO (1) | WO2012095303A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140083039A (ko) * | 2011-10-21 | 2014-07-03 | 녹손 파르마 아게 | 글루카곤 결합형 핵산 |
| BR112014016939A2 (pt) * | 2012-01-10 | 2019-09-24 | Noxxon Pharma Ag | ácidos nucleicos que se ligam especificamente a cgrp |
| US9518265B2 (en) * | 2012-01-10 | 2016-12-13 | Noxxon Pharma Ag | C5a binding nucleic acids |
| EP3793427B1 (en) | 2018-05-17 | 2026-04-01 | The Procter & Gamble Company | Systems and methods for hair coverage analysis |
| US11172873B2 (en) | 2018-05-17 | 2021-11-16 | The Procter & Gamble Company | Systems and methods for hair analysis |
| US11384357B2 (en) | 2018-06-29 | 2022-07-12 | The Procter And Gamble Company | Aptamers for personal care applications |
| WO2020214784A1 (en) | 2019-04-16 | 2020-10-22 | The Procter & Gamble Company | Aptamers for odor control applications |
| US12039732B2 (en) | 2021-04-14 | 2024-07-16 | The Procter & Gamble Company | Digital imaging and learning systems and methods for analyzing pixel data of a scalp region of a users scalp to generate one or more user-specific scalp classifications |
| WO2023247651A1 (en) | 2022-06-21 | 2023-12-28 | TME Pharma AG | Methods for treating a tumor in a subject |
| EP4306640A1 (en) | 2022-06-21 | 2024-01-17 | TME Pharma AG | Method for treating a tumor in a subject |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR970002255B1 (ko) | 1990-06-11 | 1997-02-26 | 넥스스타 파아마슈티컬드, 인크. | 핵산 리간드 |
| US6011020A (en) | 1990-06-11 | 2000-01-04 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligand complexes |
| AU743469C (en) | 1996-08-30 | 2004-02-12 | Rolf Bald | Mirror-symmetrical selection and evolution of nucleic acids |
| US6395029B1 (en) | 1999-01-19 | 2002-05-28 | The Children's Hospital Of Philadelphia | Sustained delivery of polyionic bioactive agents |
| US6652886B2 (en) | 2001-02-16 | 2003-11-25 | Expression Genetics | Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents |
| EP1264603B8 (en) | 2001-06-10 | 2010-03-03 | Noxxon Pharma AG | Use of L-polynucleotides for in vivo imaging |
| EP1306382A1 (de) | 2001-10-26 | 2003-05-02 | Noxxon Pharma AG | Modifizierte L-Nukleinsäure |
| DK2431377T3 (en) | 2001-10-26 | 2017-08-14 | Noxxon Pharma Ag | Modified L-nucleic acids |
| ATE441706T1 (de) | 2002-02-20 | 2009-09-15 | Gen Hospital Corp | Konjugate mit biologisch abbaubarem polymer und verwendung dafür |
| MXPA05011022A (es) | 2003-04-13 | 2006-04-27 | Enzon Pharmaceuticals Inc | Profarmacos oligonucleotidos polimericos. |
| GB0314472D0 (en) | 2003-06-20 | 2003-07-23 | Warwick Effect Polymers Ltd | Polymer |
| EA009376B1 (ru) | 2003-11-10 | 2007-12-28 | Нокссон Фарма Аг | Нуклеиновые кислоты, специфично связывающие биоактивный грелин |
| US20090281296A1 (en) | 2004-02-09 | 2009-11-12 | Supramol Parenteral Colloid Gmbh | Process for the production of conjugates from polysaccharides and polynucelotides |
| WO2005099768A2 (en) | 2004-03-23 | 2005-10-27 | Complex Biosystems Gmbh | Polymeric prodrug with a self-immolative linker |
| US7579450B2 (en) | 2004-04-26 | 2009-08-25 | Archemix Corp. | Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics |
| CA2585664C (en) | 2004-11-05 | 2014-05-20 | The Children's Hospital Of Philadelphia | Biodegradable linkers for molecular therapies |
| US20090075342A1 (en) | 2005-04-26 | 2009-03-19 | Sharon Cload | Metabolic profile directed aptamer medicinal chemistry |
| US20120101267A1 (en) | 2005-10-07 | 2012-04-26 | Alison Velyian Todd | Multicomponent nucleic acid enzymes with cleavage, ligase or other activity and methods for their use |
| EP2385141B1 (en) | 2005-10-07 | 2013-08-07 | SpeeDx Pty Ltd | Multicomponent nucleic acid enzymes and methods for their use |
| MX2009002859A (es) | 2006-09-15 | 2009-03-30 | Enzon Pharmaceuticals Inc | Enlazadores biodegradables a base de ester impedido para suministro de oligonucleotidos. |
| MX2009010710A (es) | 2007-04-05 | 2009-12-08 | Johnson & Johnson Res Pty Ltd | Complejos y enzimas de acido nucleico y metodos para su uso. |
| CA2732142A1 (en) * | 2008-07-28 | 2010-02-04 | Idera Pharmaceuticals, Inc. | Modulation of toll-like receptor 9 expression by antisense oligonucleotides |
| EP2561079A1 (en) | 2010-04-21 | 2013-02-27 | Noxxon Pharma AG | Lipid binding nucleic acids |
-
2012
- 2012-01-10 EP EP12700093.3A patent/EP2663640B1/en active Active
- 2012-01-10 JP JP2013547842A patent/JP2014504865A/ja active Pending
- 2012-01-10 AU AU2012206750A patent/AU2012206750A1/en not_active Abandoned
- 2012-01-10 KR KR1020137017897A patent/KR20140026357A/ko not_active Ceased
- 2012-01-10 WO PCT/EP2012/000089 patent/WO2012095303A1/en not_active Ceased
- 2012-01-10 CN CN201280007720XA patent/CN103339258A/zh active Pending
- 2012-01-10 US US13/978,804 patent/US9976145B2/en active Active
- 2012-01-10 CA CA2824073A patent/CA2824073A1/en not_active Abandoned
- 2012-01-10 KR KR1020197016125A patent/KR102080142B1/ko active Active
-
2017
- 2017-04-05 JP JP2017075557A patent/JP2017148055A/ja active Pending
-
2018
- 2018-05-21 US US15/985,626 patent/US20190367921A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017536119A5 (enExample) | ||
| JP2020532961A5 (enExample) | ||
| Pu et al. | Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment | |
| JP2013511990A5 (enExample) | ||
| JP2019216733A5 (enExample) | ||
| JP2012105686A5 (enExample) | ||
| JP2014511686A5 (enExample) | ||
| JP2014513954A5 (enExample) | ||
| JP2014504857A5 (enExample) | ||
| WO2008150729A3 (en) | N-substituted-aminomethylene bridged bicyclic nucleic acid analogs | |
| RU2016123086A (ru) | Способы и композиции для лечения болезни хантингтона | |
| JP2016530294A5 (enExample) | ||
| JP2015517806A5 (enExample) | ||
| JP2008283975A5 (enExample) | ||
| JP2017070307A5 (enExample) | ||
| JP2009524696A5 (enExample) | ||
| JP2017079759A5 (enExample) | ||
| JP2012505657A5 (enExample) | ||
| JP2012050438A5 (enExample) | ||
| JP2013535212A5 (enExample) | ||
| JP2013524792A5 (enExample) | ||
| JP2015128433A5 (enExample) | ||
| JP2017523781A5 (enExample) | ||
| JP2014516027A5 (enExample) | ||
| JP2023504048A5 (enExample) |